HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julia Schüler Selected Research

Panobinostat

12/2015The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julia Schüler Research Topics

Disease

26Neoplasms (Cancer)
02/2024 - 05/2007
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 12/2015
3Prostatic Neoplasms (Prostate Cancer)
01/2017 - 02/2015
2Malignant Mesothelioma
02/2024 - 01/2023
2Mesothelioma
02/2024 - 01/2023
2Carcinogenesis
04/2022 - 06/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2022 - 06/2015
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 06/2015
2Renal Cell Carcinoma (Grawitz Tumor)
05/2021 - 08/2014
2Adenocarcinoma
01/2021 - 05/2011
2Lung Neoplasms (Lung Cancer)
01/2021 - 05/2011
2Lymphoma (Lymphomas)
05/2015 - 07/2012
2Liver Neoplasms (Liver Cancer)
12/2014 - 01/2013
2Hepatocellular Carcinoma (Hepatoma)
12/2014 - 01/2012
1Hypoxia (Hypoxemia)
02/2022
1Breast Neoplasms (Breast Cancer)
01/2021
1Emotional Exhaustion
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2019
1Acinar Cell Carcinoma
10/2016
1Adenocarcinoma of Lung
12/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2013
1Multiple Myeloma
04/2013

Drug/Important Bio-Agent (IBA)

4Messenger RNA (mRNA)IBA
01/2022 - 05/2007
3EpitopesIBA
06/2015 - 07/2012
2Cisplatin (Platino)FDA LinkGeneric
02/2024 - 01/2023
2Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2017
2Proteasome Endopeptidase Complex (Proteasome)IBA
05/2021 - 01/2021
2Taxoids (Taxanes)IBA
01/2021 - 01/2017
2Docetaxel (Taxotere)FDA Link
01/2017 - 01/2017
2Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 02/2015
2Histone Deacetylase InhibitorsIBA
12/2015 - 06/2015
24-methylthiobutyl isothiocyanateIBA
12/2014 - 01/2013
1NivolumabIBA
02/2024
1Phosphatidylinositols (Phosphatidylinositol)IBA
02/2024
1Phosphotransferases (Kinase)IBA
02/2024
1Pemetrexed (MTA)FDA Link
01/2023
1SolitomabIBA
01/2023
1Anaplastic Lymphoma KinaseIBA
01/2023
1Chalcone (Benzalacetophenone)IBA
01/2023
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2023
1TubulinIBA
01/2023
1HydrogelsIBA
01/2023
1Ouabain (G Strophanthin)IBA
02/2022
1EmetineIBA
02/2022
1LigandsIBA
01/2022
1Type 4 Fibroblast Growth Factor ReceptorIBA
01/2022
1IntegrinsIBA
01/2022
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2022
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2021
1Anaphase-Promoting Complex-CyclosomeIBA
01/2021
1AntigensIBA
01/2021
1Antimitotic AgentsIBA
01/2021
1UbiquitinIBA
01/2021
1Cyclin BIBA
01/2021
1Ligases (Synthetase)IBA
01/2021
1N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA
01/2021
1BuffersIBA
01/2021
1Bortezomib (Velcade)FDA Link
01/2021
1CytokinesIBA
10/2019
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2019
1Interleukin-2 (IL2)IBA
10/2019
1Hematoxylin (Haematoxylon)IBA
07/2019
1Eosine Yellowish-(YS) (Eosin)IBA
07/2019
1navitoclaxIBA
01/2019
1Metformin (Glucophage)FDA LinkGeneric
01/2019
1venetoclaxIBA
01/2019
1taxaneIBA
01/2017
1Androgen Receptors (Androgen Receptor)IBA
01/2017
1AndrogensIBA
01/2017
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2016
1Lipase (Acid Lipase)FDA Link
10/2016
1ChromatinIBA
12/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2015
1PanobinostatIBA
12/2015
1mocetinostatIBA
06/2015
1Testosterone (Sustanon)FDA Link
05/2015
1Capsules (Microcapsules)IBA
05/2015
1nilotinibFDA Link
02/2015
1PhosphotyrosineIBA
02/2015
1ProteomeIBA
02/2015
1Hormones (Hormone)IBA
02/2015
1Tyrosine Kinase InhibitorsIBA
02/2015
1sulforaphaneIBA
12/2014
1erucinIBA
12/2014
1EnzymesIBA
12/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
12/2014
1isothiocyanic acidIBA
12/2014
1tetra(4-N-methylpyridyl)porphineIBA
12/2014
1Aligeron (AS 2)IBA
02/2014
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2013
1Insulin (Novolin)FDA Link
08/2013
1Sorafenib (BAY 43-9006)FDA Link
04/2013

Therapy/Procedure

11Therapeutics
01/2023 - 05/2011
3Drug Therapy (Chemotherapy)
02/2022 - 02/2015
1Aftercare (After-Treatment)
02/2024
1Investigational Therapies (Experimental Therapy)
01/2021
1Immunotherapy
01/2021
1Prostatectomy (Retropubic Prostatectomy)
05/2015
1Heterologous Transplantation (Xenotransplantation)
05/2015